| Evaluating a multi-biomarker panel for the early detection of ovarian cancer |
Maxwell Akonde |
University of South Carolina |
PLCO |
Apr 8, 2022 |
PLCO-966 |
| Evaluating Body Mass Index with total and cause-specific mortality by age groups |
Zheng Guo |
Vanderbilt University Medical Center |
PLCO |
Jan 10, 2025 |
PLCO-1783 |
| Evaluating cancer mortality in the National Lung Screening Trial |
Chiung-Yu Huang |
Johns Hopkins University |
NLST |
Apr 18, 2014 |
NLST-69 |
| Evaluating circulating immunologic markers in the development of multiple myeloma |
Jonathan Hofmann |
NCI |
PLCO |
Mar 16, 2018 |
PLCO-355 |
| Evaluating comorbidities and life expectancy in patients undergoing LDCT screening in the real world setting |
Jonathan Iaccarino |
Boston University Medical Campus |
NLST |
May 19, 2017 |
NLST-309 |
| Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. |
Lauren King |
NCI-DCEG |
PLCO |
Jan 30, 2020 |
PLCO-576 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
NLST |
Apr 13, 2019 |
NLST-498 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Oct 27, 2020 |
PLCO-683 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the NLST data |
Dongfeng Wu |
University of Louisville |
NLST |
May 16, 2014 |
NLST-73 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data |
Dongfeng Wu |
University of Louisville |
PLCO |
May 21, 2014 |
PLCO-86 |
| Evaluating Predictors of Improved Outcomes Among Patients Undergoing Surgery for Lung Cancer |
Chi-Fu Jeffrey Yang |
Massachusetts General Hospital |
NLST |
Jun 21, 2022 |
NLST-922 |
| Evaluating risk factor-based strategies for oversampling of individuals at higher risk of cancer for bioscpecimen collection and prospective assessment of Multi-Cancer Detection assays |
Filip Pirsl |
National Cancer Institute |
PLCO |
Oct 11, 2024 |
PLCO-1704 |
| Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial |
Timothy Church |
University of Minnesota |
PLCO |
Mar 31, 2006 |
2006-0307 |
| Evaluating six-step parsimonious quadratic logistic regression for risk prediction |
Stuart Baker |
National Cancer Institute |
NLST |
Jun 12, 2020 |
NLST-676 |
| Evaluating six-step parsimonious quadratic logistic regression for risk prediction |
Stuart Baker |
National Cancer Institute |
PLCO |
Jun 18, 2020 |
PLCO-637 |
| Evaluating the Cost-Effectiveness of the Sybil Model for Lung Nodule Surveillance in Cancer Screening |
Kei Chuen Ma |
Massachusetts Institute of Technology |
NLST |
Apr 18, 2024 |
NLST-1235 |
| Evaluating the Impact of Preoperative Characteristics on Outcomes of Patients Undergoing Curative-intent Treatment in the NLST |
Chi-Fu Yang |
Stanford |
NLST |
Nov 25, 2019 |
NLST-607 |
| Evaluating the Impact of Radiologist Experience and AI Integration on Lung Cancer Screening Performance: A Comparative Analysis of a Leading Dutch Radiology Center Using NLST Data |
Alex Puiu |
PRMSE-SCREENING |
NLST |
Dec 16, 2024 |
NLST-1368 |
